作为一座桥梁,ECPELLA在耐火性心脏性休克中作出决定:一个单中心的经验
Jan-Willem Balder1, Mariusz K Szymanski2, Linda W van Laake2
1Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands. j.balder@umcutrecht.nl.
概括
ECPELLA是体外膜氧化和Impella的组合,为左心室辅助装置植入或在耐火性心脏性休克中恢复提供了一座桥梁. 这种暂时的机械支显示出有希望的结果,尽管存在相关的并发症.
科学领域:
- 心脏病学 心脏病学
- 机械循环支持 机械循环支持
- 关键护理医学 关键护理医学
背景情况:
- 耐心心脏性休克需要暂时的机械支持 (tMCS) 进行 perfusion.
- tMCS 作为左心室辅助器件 (LVAD) 或心脏移植的决定桥梁,或作为恢复的桥梁.
- ECPELLA是一种新的tMCS,将静脉外体膜氧化与Impella相结合.
研究的目的:
- 介绍ECPELLA支持的患者的临床参数,结果和并发症.
- 评估ECPELLA作为耐火性心脏性休克的桥梁策略.
主要方法:
- 乌得勒支大学医学中心ECPELLA支持患者的回顾性分析 (2020年12月 - 2023年8月).
- 主要结局:30天死亡率.
- 二次结局:LVAD植入,心脏移植和安全事件.
主要成果:
- 包括20名患有急性或慢性心力衰竭的患者 (平均年龄51岁,男性70%).
- 50%接受了LVAD植入;30%在30天内实现了心脏恢复.
- 30天死亡率为20%,并发症包括严重出血 (40%),血液溶解 (25%) 和功能衰竭 (50%).
结论:
- 埃克佩拉是一种可行的桥梁策略,用于LVAD植入或在耐火性心脏性休克中恢复.
- 观察到的30天死亡率低于之前的研究,尽管并发症率很高.
相关概念视频
Cardiopulmonary Resuscitation III: AED Use
1.7K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790


